Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study

Creative Commons License

Kohli P., Wallentin L., Reyes E., Horrow J., Husted S., Angiolillo D. J., ...Daha Fazla

CIRCULATION, cilt.127, sa.6, ss.673-681, 2013 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 127 Sayı: 6
  • Basım Tarihi: 2013
  • Doi Numarası: 10.1161/circulationaha.112.124248
  • Dergi Adı: CIRCULATION
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.673-681
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Background-We sought to evaluate the effect of potent platelet inhibition after acute coronary syndrome on total (ie, first and recurrent) occurrences of any of the primary outcome events (eg, cardiovascular death, myocardial infarction, and stroke) as well as on other ischemic events, such as urgent revascularization, (severe) recurrent ischemia, transient ischemic attacks, and arterial thrombotic events.